| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sagimet Biosciences Inc. (SGMT) has 5 insiders with recent SEC Form 4 filings, including 5 buys and 2 sells. SGMT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 741.6K | $6.41M | -64,051 | |
| Other | 224.4K | $1.94M | -10,545 | |
| Dir | 62.2K | $537.1K | -18,844 | |
| CFO | 50.0K | $432.0K | - | |
| Other | 35.0K | $302.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2024 | Kemble George | Executive Chairman | Sell | 14,062 | $3.10 | $43,604.86 | -9.0% | +74.8% | +204.5% | |
| Mar 26, 2024 | Happel David71 | President &CEO | Buy | 12,100 | $5.27 | $63,730.70 | +1.9% | -19.7% | -24.5% | |
| Dec 7, 2023 | Happel David71 | President &CEO | Buy | 1,600 | $4.10 | $6,560.00 | +0.3% | +65.1% | +26.2% | |
| Nov 16, 2023 | Happel David71 | President &CEO | Buy | 590 | $2.35 | $1,386.50 | New | +247.2% | +103.0% | |
| Jul 18, 2023 | New Enterprise Associates 13 LP68 | 10% Owner | Sell | 662 | $16.00 | $10,592.00 | - | -63.0% | -78.7% | |
| Jul 18, 2023 | New Enterprise Associates 13 LP68 | 10% Owner | Buy | 30,000 | $16.00 | $480,000.00 | +0.8% | -63.0% | -78.7% | |
| Jul 18, 2023 | Seidenberg Beth C75 | Director | Buy | 46,875 | $16.00 | $750,000.00 | New | -63.0% | -78.7% |